The largest ever review of cardiovascular safety of hydroxychloroquine in patients with arthritic disorders has flagged a potential raised risk of cardiovascular death with long term use in patients with RA. The disease-modifying drug has been routinely used for many years in the treatment of RA and SLE, and rheumatologists are familiar with risks highlighted ...
Long term hydroxychloroquine use raises cardiovascular mortality in RA patients: review
By Anna Sayburn
2 Sep 2020